30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Craig Collard

Track

Insider profile

Currently holds a position at Opiant Pharmaceuticals Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 38% 68% 82%
Transactions
8 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Opiant Pharmaceuticals Inc Oct. 29, 2018 -
Craig Collard's trades of Heron Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-17 2023-11-16
B Purchase
64,719 -26.4%
84.07
US$4,116,650 		64,719 -26.4% 84.07 US$4,116,650
2022-09-27 2022-09-23
B Purchase
97,043
413.42
US$3,040,062 		97,043 413.42 US$3,040,062
2022-09-26 2022-09-22
B Purchase
73,764
440.06
US$4,652,968 		73,764 440.06 US$4,652,968
2022-06-13 2022-06-13
B Purchase
4,037 +8.1%
10.94
US$44,149 		4,037 +8.1% 10.94 US$44,149
2022-06-13 2022-06-10
B Purchase
1,663 +3.5%
11.50
US$19,118 		1,663 +3.5% 11.50 US$19,118
2022-05-17 2022-05-16
B Purchase
27,150 +129.5%
13.54
US$367,611 		27,150 +129.5% 13.54 US$367,611
2022-05-16 2022-05-13
B Purchase
3,689 +21.3%
10.49
US$38,698 		3,689 +21.3% 10.49 US$38,698
2021-11-24 2021-11-24
B Purchase
7,899 +141.0%
23.09
US$182,348 		7,899 +141.0% 23.09 US$182,348
2021-11-24 2021-11-23
B Purchase
5,601 +inf%
22.95
US$128,515 		5,601 +inf% 22.95 US$128,515
2021-09-13 2021-09-10
B Purchase
9,577 +239.4%
18.18
US$174,110 		9,577 +239.4% 18.18 US$174,110